Bayer Cuts 2023 Outlook Amid Slump in Prices for Roundup

Kering Said to Tap Defense Advisers as Activist Bluebell Circles

European Stocks Steady as China Data Points to Weaker Recovery

EU Ignites Battle Over Relaxed GMO Crop Rules in Green Push

OBS Group Nearing Deal for Bayer Pharma Assets in Pakistan, Sources Say

GSK Settles First Zantac Cancer Lawsuit Set for Trial in US

Europe’s Economic Engine Is Breaking Down

US Exposure Is Next Headache for Europe Inc. as Dollar Slides

Global Carbon Market in Turmoil After Zimbabwe Grabs Offset Money

Bayer Sees Profit at Low End of Target as Weedkiller Tumbles